Linked Life Data

20722660

Source:http://linkedlifedata.com/resource/pubmed/id/20722660

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2010-10-29
pubmed:abstractText
The correction of soft tissue contour defects and dermal atrophy is a growing area driven by medical and aesthetic need. Deterioration of the skin's appearance occurs as a result of age and trauma, such as surgery, infections, and acne. Typically, imperfections are treated with volume-correcting fillers. This study evaluated allogeneic human dermal fibroblasts (HDFs) for the treatment of nasolabial folds as an alternative strategy to improve the structure, texture, and quality of the skin.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1524-4725
pubmed:author
pubmed:copyrightInfo
© 2010 by the American Society for Dermatologic Surgery, Inc.
pubmed:issnType
Electronic
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1578-85
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
A phase IIa open-label dose-escalation pilot study using allogeneic human dermal fibroblasts for nasolabial folds.
pubmed:affiliation
Department of Dermatology, School of Medicine, University of California at Los Angeles, Los Angeles, California, USA. cranley@cranleyclinic.com
pubmed:publicationType
Journal Article, Clinical Trial, Phase II